Virpax Pharmaceuticals Inc (VRPX) — Financial Flexibility Index
Virpax Pharmaceuticals Inc (VRPX) has a Financial Flexibility Index of -1.16x as of December 2024. Free cash flow of $-2.87 Million (operating CF $-2.87 Million minus capex $0.00) represents -1% of total liabilities ($2.47 Million). Check Virpax Pharmaceuticals Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Virpax Pharmaceuticals Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Virpax Pharmaceuticals Inc across 7 annual periods. See Virpax Pharmaceuticals Inc (VRPX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Virpax Pharmaceuticals Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Virpax Pharmaceuticals Inc. For the full company profile including market capitalisation, see Virpax Pharmaceuticals Inc (VRPX) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.77x | $-16.71 Billion | $-16.71 Billion | $2.47 Billion | ▼ -428.5% |
| 2023 | -1.28x | $-9.85 Million | $-9.85 Million | $7.69 Million | ▲ +77.8% |
| 2022 | -5.77x | $-17.85 Million | $-17.85 Million | $3.09 Million | ▲ +17.2% |
| 2021 | -6.97x | $-14.54 Million | $-14.54 Million | $2.09 Million | ▼ -2254.8% |
| 2020 | -0.30x | $-1.38 Million | $-1.38 Million | $4.68 Million | ▲ +27.4% |
| 2019 | -0.41x | $-1.13 Million | $-1.13 Million | $2.78 Million | ▲ +71.6% |
| 2018 | -1.43x | $-1.80 Million | $-1.80 Million | $1.25 Million | — |